Differentiated Thyroid Cancer (DTC) Recruiting Phase 3 Trials for CM-4307 (DB15414)

Also known as: Differentiated Thyroid Cancer

IndicationStatusPhase
DBCOND0062237 (Differentiated Thyroid Cancer (DTC))Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03602495Donafenib in 131I-Refractory Differentiated Thyroid CancerTreatment